Advicenne Announces Long-Term Results of the European Clinic

Regulatory News: Advicenne(Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering

Related Keywords

Milan , Lombardia , Italy , Canada , Vilnius , Vilniaus Apskritis , Lithuania , Paris , France General , France , French , Marta Giaccari , Advicenne Euronext , Didier Laurens , European Renal Association , European Society Of Pediatric Nephrology , Regulatory News , Euronext Growth Paris , Renal Tubular Acidosis , Renal Association , Focused Orals , Pediatric Nephrology , European Society , Marketing Approval , Euronext Paris , Registration Document , Advicenne , Nnounces , Song , Term , Results , European , Linical , Development , Program , Dv7103 ,